Enterovirus D68 in the United States: Epidemiology, Diagnosis & Treatment

Date:Tuesday, September 16, 2014

Time:2:00 – 3:00 PM (Eastern Time)

Presenter(s)

Overview

Hospitals across the U.S., especially in Missouri and Illinois, are seeing more children with severe respiratory illness caused by enterovirus D68 (EV-D68). Several states are also investigating similar clusters of severe respiratory illness. There are no vaccines for preventing EV-D68 infections. Clinicians should consider EV-D68 as a potential cause of clusters of severe respiratory illness, particularly in children. During this COCA call, clinicians will learn about the current EV-D68 situation in the U.S., laboratory testing, reporting suspected clusters, and approaches to prevention and treatment.

Objectives

At the conclusion of the session, the participant will be able to accomplish the following:

• Discuss the current EV-D68 situation in the United States, including clusters in Missouri and Illinois
• Describe the procedures for laboratory testing and reporting clusters of suspected cases
• Explain prevention and treatment strategies to address EV-D68

Call Materials

• Audio: Listen Now
• Slides: Read Now
• Transcript: Read Now

Additional Resources

• CDC Non-Polio Enterovirus D68
• CDC Non-Polio Enterovirus For Health Care Professionals
• CDC Non-Polio Enterovirus References and Resources

Call Format

• Audio conference call on 9/16/14: 2:00 - 3:00 PM
• Web-on-demand training after 3:00 PM on 9/18/14
• Materials: PowerPoint slide set

Accreditation Statements

Accreditation Statements

CME:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME^®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this live activity for a maximum of 0.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE:The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity provides 0.0 contact hour.

IACET CEU:The CDC has been approved as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 1760 Old Meadow Road, Suite 500, McLean, VA 22102. The CDC is authorized by IACET to offer 0.0 ANSI/IACET CEU's for this program.

CECH:Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 0 Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number GA0082.

CPE:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 0.0 Contact Hour in pharmacy education. The Universal Activity Number is 0387-0000-14-166-L04-P and enduring 0387-0000-14-166-H04-P course category.

This program is knowledge based.

AAVSB/RACE:This program was reviewed and approved by the AAVSB RACE program for 0.0 hours of continuing education in the jurisdictions which recognize AAVSB RACE approval. Please contact the AAVSB RACE Program at race@aavsb.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.

DISCLOSURE:In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.

The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC does not accept commercial support.